Market Research

Pune, India – September 25, 2026 -- The global nanomedicine market reached USD 207.91 billion in 2025 and is projected to hit USD 581.2 billion by 2034, expanding at a 12.1% compound annual growth rate, according to a new report from Maximize Market Research.

North America commands the largest share on pharmaceutical R&D strength

North America held the largest share of the market in 2025, driven by advanced healthcare infrastructure, deep pharmaceutical and biotechnology research pipelines, and high healthcare expenditure. The United States anchors regional growth through its established research ecosystem and rising adoption of nanotechnology-based drug delivery, diagnostics and precision medicine platforms. Canada and Mexico are contributing through expanding healthcare capabilities and research initiatives.

Pune, India – September 25, 2026 -- The global multiple sclerosis treatment market reached USD 26.76 billion in 2025 and is forecast to climb to USD 44.45 billion by 2034, expanding at a 5.8% CAGR, according to a new report from Maximize Market Research.

Disease-modifying therapies and biologics drive current market expansion

Rising MS prevalence, improved diagnostic capabilities, and growing adoption of immunomodulators, immunosuppressants, interferons, oral disease-modifying therapies (DMTs), and monoclonal antibodies are fueling demand across relapsing-remitting (RRMS), primary progressive (PPMS), secondary progressive (SPMS), and clinically isolated syndrome (CIS) patient segments. High-efficacy biologics and oral treatment options are increasingly displacing older therapy classes as patients and physicians prioritize convenience and disease-progression control.

Pune – September 25, 2026 -- The global bioinformatics market is projected to expand from $20.34 billion in 2025 to $64.60 billion by 2034, a 13.7% compound annual growth rate, according to new analysis from Maximize Market Research.

Genomic data volumes and NGS adoption fuel core demand

Rising volumes of genomic and biological data, driven by expanding next-generation sequencing (NGS) adoption, are pushing pharmaceutical and biotechnology companies toward advanced bioinformatics platforms, sequencing data analysis tools, and biological databases. Declining sequencing costs are drawing smaller research institutions into the market, while growing precision medicine applications are increasing demand for pharmacogenomics, biomarker analysis, and genomic diagnostics.

Pune, India – September 24, 2026 -- The global bladder cancer treatment market was valued at $5.13 billion in 2025 and is projected to reach $11.33 billion by 2034, expanding at a 9.2% compound annual growth rate, according to a new analysis from Maximize Market Research.

Immunotherapy and antibody-drug conjugates drive treatment shift

Adoption of immune checkpoint inhibitors, antibody-drug conjugates (ADCs), and FGFR inhibitors is accelerating across non-muscle-invasive and muscle-invasive bladder cancer segments. Pharmaceutical companies are directing R&D spend toward intravesical drug delivery, gene therapy, and biomarker-driven precision oncology to improve outcomes for recurrent and metastatic urothelial cancer patients.

Washington – September 24, 2026 -- App-based rideshare and delivery platforms supported $414 billion in U.S. economic activity in 2025, according to a new study commissioned by Flex, the trade association representing the sector's leading companies.

Drivers and couriers completed 6.3 billion orders, earning $8.9 billion in supplemental income

Some 9.4 million drivers and couriers completed a combined 6.3 billion rideshare and delivery orders with Flex member companies last year, generating $8.9 billion in additional income for workers. Order volume rose 29 percent since 2022, the report found.

Pune, India – – September 23, 2026 -- The global exosomes market is set to grow nearly tenfold over the next decade, expanding from USD 230.55 million in 2025 to USD 2,250 million by 2034, according to a new analysis from Maximize Market Research. The projected 28.8% compound annual growth rate between 2026 and 2034 places exosome technology among the fastest-expanding segments in biopharmaceutical R&D.

Drug delivery pipelines drive commercial momentum

Pharmaceutical and biotechnology companies are expanding exosome-related pipelines as the nanosized extracellular vesicles gain traction as targeted carriers for drugs, proteins, and RNA. Rising investment in biotechnology and advances in isolation, characterization, and engineering technologies are pushing exosomes beyond research settings into drug development and regenerative medicine applications.

Palo Alto – September 23, 2026 -- Aragon Research has published its second annual Globe report for Strategic Response Management (SRM), evaluating 14 technology providers as the market moves from reactive AI assistants to fully autonomous agentic systems.

Market expands beyond RFP automation to cover security questionnaires and complex sales bids

The 2026 Aragon Research Globe for SRM assesses vendors managing not just requests for proposals but also RFIs and security questionnaires, reflecting a broader shift in enterprise response management. Aragon Research CEO and Lead Analyst Jim Lundy stated that the industry is entering the age of the "AI coworker," where autonomous agents handle multi-step tasks without constant human oversight.

Sheridan, Wyoming – – September 23, 2026 -- The global lateral flow assay market is set to expand from $11.04 billion in 2026 to $16.37 billion by 2031, a compound annual growth rate of 8.2%, according to a new study by Wissen Research.

Calgary – September 22, 2026 -- Forty-one percent of adults under 45 in the U.S. and Canada now pay for services that family and friends once provided, more than double the 18% reported by adults aged 62-80, according to a new study from Cashew Research.

The survey of 2,002 adults, titled The Capacity Gap, found that social support networks remain intact but are failing to convert into practical help. Seventy percent of respondents said they have a good emotional support system and 67% feel connected to a community, yet a widening share are turning to paid services to fill the gap between having support and having the time to use it.

Delray Beach – September 22, 2026 -- The global heat transfer fluids market is projected to expand from $5.33 billion in 2026 to $6.60 billion by 2031, a 4.4% compound annual growth rate, according to a new report from MarketsandMarkets.

Asia Pacific leads growth as chemical and electronics output expands

Asia Pacific is both the largest and fastest-growing regional market, expanding at a 5.1% CAGR through 2031. China, India, Japan, South Korea and Southeast Asian manufacturing hubs are driving demand for process heating and temperature-control solutions across chemicals, automotive, electronics and pharmaceutical production, alongside rising investment in data centers and HVAC infrastructure.